Newspaper Publication for Unaudited statndalone financial Statement for the quarter and nine months ended on 31st Decemeber, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jenburkt Pharmaceuticals has informed the stock exchange that it published its standalone unaudited financial results for the third quarter and nine months ended 31st December 2025 in two newspapers — The Free Press Journal (English) and Navshakti (Marathi) — on 4th February 2026. The board had approved these results at its meeting held on 3rd February 2026. The detailed financial figures themselves are not reproduced in the filing and are available on the BSE website and the company's investor page. The publication has been done to comply with SEBI listing rules that require companies to publish quarterly results in newspapers.
This is a routine regulatory compliance filing with no direct impact on the stock price. Investors should look at the actual financial results (revenue, profit, margins) published on BSE and the company website to assess the company's Q3 performance.